|
Chronic Pain Modulation of Mesolimbic Dopamine Signaling for Natural and Opiate Rewards |
1F31DA056200-01 |
|
NIDA |
2022 |
|
Neurocognitive Impairments Resulting from Adolescent Prescription Opioid Use Disorder: Longitudinal Impact, Neural Mechanisms, and Comorbidities |
1K99DA056288-01 |
|
NIDA |
2022 |
|
Mechanisms of prenatal opioid exposure on brain and behavior |
1R01DA050871-01A1 |
|
NIDA |
2022 |
|
Neurocognitive implications of cannabidiol (CBD) while aging with HIV |
1R03DA057146-01 |
|
NIDA |
2022 |
|
Psychostimulants, Attention Deficit and Basal Ganglia Disorders |
1R21DA055980-01 |
|
NIDA |
2022 |
|
Neural circuitry mediating behavioral flexibility |
3R00DA042934-05S2 |
|
NIDA |
2022 |
|
Leveraging ΔFosB as a potential therapeutic for Alzheimers Disease |
3R01DA040621-07S1 |
|
NIDA |
2022 |
|
Systems biology of RNA Modifications in HIV/AIDS and Substance Use Disorders |
3R01DA046170-05S1 |
|
NIDA |
2022 |
|
Identification of small molecules for neurological complications of HIV and substance abuse comorbidity |
3R01DA046204-05S1 |
|
NIDA |
2022 |
|
Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection-supplement |
3R01DA052845-03S1 |
|
NIDA |
2022 |